NEW YORK (GenomeWeb News) – The Institute for Genome Sciences at the University of Maryland School of Medicine has received a $1.4 million contract from the US Food and Drug Administration to sequence, assemble, and annotate a population of bacterial pathogens.

The goal of the two-year project is to generate draft sequence data that other researchers will be able to use to develop and assess new high-throughput sequencing-based in vitro diagnostics for identifying pathogens, the University of Maryland Medical Center said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.